ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT04476173
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 200 participants
- Registry
-
NCT04476173
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Poland
- Registry status
- Unknown status
Technical summary
Registry record NCT04476173. Randomized; no masking; primary purpose treatment. Start 2020-06-01 (actual); primary completion 2024-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction
- Acronym
- ANEMON
- Condition
- ST Elevation Myocardial Infarction
- Condition
- Non ST Segment Elevation Acute Coronary Syndrome
- Intervention (Drug)
- Methoxyflurane - Penthrox
- Intervention (Drug)
- Morphine
- Lead sponsor
- Collegium Medicum w Bydgoszczy
Record details
- Record id
cardio:ct-nct04476173- Content hash
6d0cf74d01941e7edd344214e046c314c0cf01fb6acfde072f885f81ce119f18